Alméciga-Díaz, C. J.
Publications
P249
PLoS One 2022.
CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.
Alméciga-Díaz, C. J.
Publications
P249
PLoS One 2022.
CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata.